Nuclear medicine is a branch of medical imaging that uses small amounts of radioactive material to diagnose and determine the severity of or treat a variety of diseases, including many types of cancers, heart disease, gastrointestinal, endocrine, neurological disorders and other abnormalities within the body. Nuclear medicine procedures can pinpoint molecular activity within the body; they offer the potential to identify the disease in its earliest stages as well as a patient’s immediate response to therapeutic interventions.
Global Nuclear Medicine Market Segments Size & Growth:
Global Nuclear medicine market size is projected to reach approximately $XX billion by the end of 2024 with a CAGR of close to XX% from $XX billion in 2017 during the forecast timeline 2018-2024.Key parameters promoting the market growth include increasing incidents of cancer and cardiac ailments, expanding SPECT AND PET applications and growing public awareness for healthcare and so on. However, the Short half-life of radiopharmaceuticals, the high capital investment required for development and stringent regulatory
Global Nuclear Medicine Market Segments Share:
Global Nuclear Medicine Market is categorised into Diagnostics which comprise of PET market and SPECT market. By Therapeutics, The market is segregated into Alpha Emitters, Beta Emitters, Brachytherapy. By Applications, The market is segmented into PET and Spect Market. By Geography, North America is projected to dominate the Global Nuclear Medicine market, and the growth in the North America economies is mainly attributed because of huge profit margins and growth prospects, Global Nuclear Medicine Market Trends:
Global Nuclear Medicine Market Research Report:
Starting from $2700
Starting from $2700
Starting from $2700
Keep up-to-date with our weekly newsletter, Media Pulse.